This is a review about c-Met, based on 59 published articles (read how Labome selects the articles), using c-Met antibody in all methods. It is aimed to help Labome visitors find the most suited c-Met antibody.
c-Met synonym: AUTS9; DFNB97; HGFR; RCCP2; c-Met; HGF receptor; HGF/SF receptor; SF receptor; met proto-oncogene tyrosine kinase; proto-oncogene c-Met; scatter factor receptor; soluble MET variant 12; tyrosine-protein kinase Met

Knockout validation
Invitrogenmouse monoclonal (3D4)
  • ELISA; mouse
  • WB (knockout); mouse; fig s1
In order to report that MET is required for neutrophil chemoattraction and cytotoxicity in response to its ligand hepatocyte growth factor, Invitrogen c-Met antibody (Invitrogen, 3D4) was used in ELISA on mouse samples and in western blot (knockout) on mouse samples (fig s1). Nature (2015) ncbi
Invitrogen
rabbit polyclonal
  • IHC; human; 1:100
In order to examine the contribution of metastasis-initiating cells to prostate cancer, Invitrogen c-Met antibody (Invitrogen, 44888G) was used in immunohistochemistry on human samples at 1:100. Prostate (2015) ncbi
mouse monoclonal (3D4)
  • ELISA; mouse
  • WB (knockout); mouse; fig s1
In order to report that MET is required for neutrophil chemoattraction and cytotoxicity in response to its ligand hepatocyte growth factor, Invitrogen c-Met antibody (Invitrogen, 3D4) was used in ELISA on mouse samples and in western blot (knockout) on mouse samples (fig s1). Nature (2015) ncbi
rabbit polyclonal
  • IHC; human; 1:100
In order to examine the contribution of cerebrospinal fluid during embryonic development, Invitrogen c-Met antibody (Invitrogen, 44888G) was used in immunohistochemistry on human samples at 1:100. Dev Neurobiol (2016) ncbi
mouse monoclonal (3D4)
  • IHC-P; human; 1:200
Invitrogen c-Met antibody (Zymed, 3D4) was used in immunohistochemistry - paraffin section on human samples at 1:200. Clin Epigenetics (2015) ncbi
rabbit polyclonal
  • WB; mouse; 1:1000; fig s3
In order to investigate the mechanisms underlying the specification of branch location, Invitrogen c-Met antibody (Invitrogen, 44888G) was used in western blot on mouse samples at 1:1000 (fig s3). Nat Cell Biol (2014) ncbi
rabbit polyclonal
  • IHC; human
In order to assess if PC1 and PC2 facilitate cancer aggressiveness, Invitrogen c-Met antibody (Invitrogen, 44888G) was used in immunohistochemistry on human samples. Int J Cancer (2015) ncbi
mouse monoclonal (3D4)
  • IC; human; 1:100
Invitrogen c-Met antibody (Life Technologies, 3D4) was used in immunocytochemistry on human samples at 1:100. Mol Endocrinol (2014) ncbi
rabbit polyclonal
  • IHC; mouse; fig 1
In order to investigate the role of mTOR and Wnt signaling proteins to c-Met TKI resistance in melanoma cell lines, Invitrogen c-Met antibody (Invitrogen, 44-882G) was used in immunohistochemistry on mouse samples (fig 1). Cancer Biol Ther (2014) ncbi
rabbit polyclonal
  • IHC; mouse
In order to use transgenic mice to determine the contribution of TGF-beta1 to lymphocyte-mediated inflammation in gastrointestinal tumorigenesis, Invitrogen c-Met antibody (Invitrogen, 44888G) was used in immunohistochemistry on mouse samples. Cancer Res (2014) ncbi
rabbit polyclonal
  • IC; mouse; 1:200
In order to study the age-associated deregulation of the satellite cell homeostatic network to identify therapeutic targets, Invitrogen c-Met antibody (Invitrogen, 718000) was used in immunocytochemistry on mouse samples at 1:200. Nat Med (2014) ncbi
rabbit polyclonal
  • WB; human; fig 3
In order to study the molecular mechanisms underlying development of resistance to tyrosine kinase inhibitors in non-small cell lung cancer, Invitrogen c-Met antibody (Invitrogen, 44882G) was used in western blot on human samples (fig 3). PLoS ONE (2013) ncbi
rabbit polyclonal
  • WB; human; fig 3
In order to discuss the use of LY2801653 in both preclinical in vitro and in vivo non-small cell lung cancer models, Invitrogen c-Met antibody (Invitrogen, 44888G) was used in western blot on human samples (fig 3). Clin Cancer Res (2013) ncbi
rabbit polyclonal
  • WB; human; fig 5
In order to examine the anticancer effect of a novel anti-c-MET Nanobody in multiple myeloma, Invitrogen c-Met antibody (Invitrogen, #44-882G) was used in western blot on human samples (fig 5). Eur J Haematol (2013) ncbi
rabbit polyclonal
  • IHC-P; human; fig 1
In order to study the biochemical activity of cabozantiinib against disease-associated RET mutants and its growth inhibitory activity in medullary thyroid cancer models, Invitrogen c-Met antibody (Biosource/Invitrogen, #44-888G) was used in immunohistochemistry - paraffin section on human samples (fig 1). Thyroid (2013) ncbi
rabbit polyclonal (CVD13)
  • IHC-P; human; fig 1
In order to study the biochemical activity of cabozantiinib against disease-associated RET mutants and its growth inhibitory activity in medullary thyroid cancer models, Invitrogen c-Met antibody (Biosource/Invitrogen, #18-2257) was used in immunohistochemistry - paraffin section on human samples (fig 1). Thyroid (2013) ncbi
rabbit polyclonal (CVD13)
  • IHC-P; human; 1:300; tbl 2
In order to examine the relationship between DDX3 and the hypoxic responsive proteins in human breast cancer, Invitrogen c-Met antibody (Zymed, 18-2257) was used in immunohistochemistry - paraffin section on human samples at 1:300 (tbl 2). PLoS ONE (2013) ncbi
mouse monoclonal (3D4)
  • IHC-F; human; 1:50; fig 4
  • WB; human; 1:250; fig 2
In order to investigate the role of c-Met in brain metastasis and test its potential as a preventive and/or therapeutic target in this disease, Invitrogen c-Met antibody (Invitrogen, 37-0100) was used in immunohistochemistry - frozen section on human samples at 1:50 (fig 4) and in western blot on human samples at 1:250 (fig 2). Clin Exp Metastasis (2013) ncbi
rabbit polyclonal
  • IHC; human; 1:50; fig 6
In order to study regenerative clusters in the liver histologically, Invitrogen c-Met antibody (Invitrogen, 44-882G) was used in immunohistochemistry on human samples at 1:50 (fig 6). Hum Pathol (2013) ncbi
rabbit polyclonal
  • WB; human; fig 3
In order to study c-Met expression and inhibition in a large cohort of renal cell carcinoma tumors and cell lines, Invitrogen c-Met antibody (Invitrogen, 44-892G) was used in western blot on human samples (fig 3). Ann Oncol (2013) ncbi
mouse monoclonal (3D4)
  • IHC-P; human; 4 ug/ml; fig 3
In order to develop and use a co-culture system to systematically assay the influence of 23 stromal cell types on the innate resistance of 45 cancer cell lines to 35 anticancer drugs, Invitrogen c-Met antibody (Invitrogen, 187366) was used in immunohistochemistry - paraffin section on human samples at 4 ug/ml (fig 3). Nature (2012) ncbi
rabbit polyclonal
  • WB; human; fig 5
In order to identify lymphangiogenic subpopulations from a melanoma of a single patient, Invitrogen c-Met antibody (Invitrogen, 44?C888G) was used in western blot on human samples (fig 5). Hum Mol Genet (2012) ncbi
rabbit polyclonal
  • WB; human; 1:500; fig 1
In order to compare multiplexed quantum dot labeling with other techniques to identify prostate cancer, Invitrogen c-Met antibody (Invitrogen, 44888G) was used in western blot on human samples at 1:500 (fig 1). PLoS ONE (2011) ncbi
rabbit polyclonal (RAC#29-10C6AC9)
  • IHC; human; 1:50; fig 3
In order to assess expression and prognostic role of the receptor tyrosine kinase MET, phosphorylated MET, and the ligand hepatocyte growth factor in patients with lung cancer, Invitrogen c-Met antibody (Biosource, 44-896) was used in immunohistochemistry on human samples at 1:50 (fig 3). J Environ Pathol Toxicol Oncol (2011) ncbi
rabbit polyclonal
  • IHC; human; 1:20; fig 3
In order to assess expression and prognostic role of the receptor tyrosine kinase MET, phosphorylated MET, and the ligand hepatocyte growth factor in patients with lung cancer, Invitrogen c-Met antibody (Biosource, 44-892G) was used in immunohistochemistry on human samples at 1:20 (fig 3). J Environ Pathol Toxicol Oncol (2011) ncbi
mouse monoclonal (3D4)
  • IHC; human; 1:100; fig 3
In order to assess expression and prognostic role of the receptor tyrosine kinase MET, phosphorylated MET, and the ligand hepatocyte growth factor in patients with lung cancer, Invitrogen c-Met antibody (Zymed, 18-7366) was used in immunohistochemistry on human samples at 1:100 (fig 3). J Environ Pathol Toxicol Oncol (2011) ncbi
rabbit polyclonal
  • IHC; human; 1:20; fig 3
In order to assess expression and prognostic role of the receptor tyrosine kinase MET, phosphorylated MET, and the ligand hepatocyte growth factor in patients with lung cancer, Invitrogen c-Met antibody (Biosource, 44-882) was used in immunohistochemistry on human samples at 1:20 (fig 3). J Environ Pathol Toxicol Oncol (2011) ncbi
rabbit polyclonal
  • IHC; human; 1:25; fig 3
In order to assess expression and prognostic role of the receptor tyrosine kinase MET, phosphorylated MET, and the ligand hepatocyte growth factor in patients with lung cancer, Invitrogen c-Met antibody (Biosource, 44-888G) was used in immunohistochemistry on human samples at 1:25 (fig 3). J Environ Pathol Toxicol Oncol (2011) ncbi
rabbit polyclonal
  • IHC-P; mouse; fig 1
In order to investigate the effect of hepatocyte growth factor on nephrin and synaptopodin expression, Invitrogen c-Met antibody (Biosource, 44-888G) was used in immunohistochemistry - paraffin section on mouse samples (fig 1). Nephrology (Carlton) (2011) ncbi
not indicated
  • WB; human
  • IP; human
Biosource anti-c-Met rabbit polyclonal antibody was used in western blot and immunoprecipitation in order to demostrate the expression of PAX 5 and the regulation for c-Met transcription in small cell lung cancer.Lab Invest (2009) ncbi
Santa Cruz Biotechnology
rabbit polyclonal (C-12)
  • IHC-P; human; 1:100
In order to determine the regeneration-associated stem cell-related phenotype of hepatocyte-derived growth factor receptor-expressing cells in active ulcerative colitis, Santa Cruz Biotechnology c-Met antibody (Santa Cruz, Clone: C-12) was used in immunohistochemistry - paraffin section on human samples at 1:100. World J Gastroenterol (2015) ncbi
rabbit polyclonal (SP260)
  • IHC-P; mouse; 1:50
  • IC; mouse; 1:50
  • WB; mouse
In order to study the biogenesis of the acrosome, Santa Cruz Biotechnology c-Met antibody (Santa Cruz, sc-162) was used in immunohistochemistry - paraffin section on mouse samples at 1:50, in immunocytochemistry on mouse samples at 1:50, and in western blot on mouse samples. Reproduction (2015) ncbi
rabbit polyclonal (C-28)
  • IHC-F; human; 1:10
In order to evaluate the therapeutical effects of gene therapy of limbal cells, Santa Cruz Biotechnology c-Met antibody (Santa Cruz biotechnology, sc-161) was used in immunohistochemistry - frozen section on human samples at 1:10. Exp Eye Res (2014) ncbi
rabbit polyclonal (SP260)
  • WB; mouse
Santa Cruz Biotechnology c-Met antibody (Santa Cruz Biotechnology, sc-162) was used in western blot on mouse samples. Am J Physiol Gastrointest Liver Physiol (2015) ncbi
rabbit polyclonal (C-28)
  • IHC-P; human; 0.2 mg/ml
Santa Cruz Biotechnology c-Met antibody (Santa Cruz, C28) was used in immunohistochemistry - paraffin section on human samples at 0.2 mg/ml. Oncotarget (2014) ncbi
rabbit polyclonal (C-28)
  • IP; human
  • IC; human
Santa Cruz Biotechnology c-Met antibody (Santa Cruz, sc-161) was used in immunoprecipitation on human samples and in immunocytochemistry on human samples. PLoS ONE (2014) ncbi
rabbit polyclonal (C-28)
  • IC; human; 1:100
Santa Cruz Biotechnology c-Met antibody (Santa Cruz, sc-161) was used in immunocytochemistry on human samples at 1:100. Mol Endocrinol (2014) ncbi
rabbit polyclonal (C-28)
  • IP; human
Santa Cruz Biotechnology c-Met antibody (Santa Cruz, sc-161) was used in immunoprecipitation on human samples. Mol Cell Biol (2014) ncbi
rabbit polyclonal (C-12)
  • IHC-P; human; 1:200
Santa Cruz Biotechnology c-Met antibody (Santa Cruz Biotechnology, SC-10) was used in immunohistochemistry - paraffin section on human samples at 1:200. Inflamm Bowel Dis (2014) ncbi
rabbit polyclonal (C-28)
  • IHC-P; mouse
In order to investigate the role of hepatocyte growth factor receptor, c-met in renoprotection, Santa Cruz Biotechnology c-Met antibody (Santa Cruz, sc-161) was used in immunohistochemistry - paraffin section on mouse samples. Kidney Int (2013) ncbi
rabbit polyclonal (C-12)
  • WB; human
Santa Cruz Biotechnology c-Met antibody (Santa Cruz, C-12) was used in western blot on human samples. Oncogene (2014) ncbi
not indicated
  • WB; human
Santa antibodies against c-Met were used to do western blot in order to investigate the role of the progesterone receptor A and c-Met in spheroids-endometrium.Reprod Biol Endocrinol (2009) ncbi
not indicated
  • IHC; human
  • FC; human
Santa Cruz rabbit anti-cMet sc-161 was used to perform immunohistochemistry in order to study the role of Pax7 in human satellite stem cell differentiation and self renewal.Dev Dyn (2009) ncbi
not indicated
  • WB; human
Santa Cruz Biotechnology anti-Met SP260 and C-12 antibodies were used in western blot and immunoprecipitation to identify LRIG1 as a novel negative regulator of the Met receptor and its role on opposing Met and Her2 synergyMol Cell Biol (2007) ncbi
not indicated
  • WB; human
  • IHC; human
Santa Cruz Biotechnology c-met antibody was used in western blot and immunohistochemistry to investigate the distribution of HGF, c-met, and HGF activator (HGFA) protein during folliculogenesis in equine chorionic gonadotropin (eCG) primed rats.Reproduction (2006) ncbi
not indicated
  • WB; human
Santa Cruz Biotechnology rabbit polyclonal anti-HGF-R antibody was used in western blot to study the role for hepatocyte growth factor in promoting lymphatic vessel formation and function in human dermal BVEC and LEC.EMBO J (2005) ncbi
Abcam
goat polyclonal
  • WB; human
In order to study the role of ADAM17 in cellular senescence and senescence secretome, Abcam c-Met antibody (Abcam, ab10728) was used in western blot on human samples. Breast Cancer Res (2015) ncbi
rabbit monoclonal (EP1454Y)
  • IHC; human
Abcam c-Met antibody (Abcam, ab51067) was used in immunohistochemistry on human samples. J Nucl Med (2014) ncbi
rabbit polyclonal
  • WB; human
Abcam c-Met antibody (Abcam, ab47606) was used in western blot on human samples. Evid Based Complement Alternat Med (2013) ncbi
rabbit monoclonal (EP1454Y)
  • WB; human
Abcam c-Met antibody (Abcam, ab51067) was used in western blot on human samples. Evid Based Complement Alternat Med (2013) ncbi
goat polyclonal
  • Neut; mouse; 1.5 g/mL
Abcam c-Met antibody (Abcam, ab10728) was used in neutralization on mouse samples at 1.5 g/mL. J Biomed Res (2012) ncbi
rabbit monoclonal (EP1454Y)
  • FC; rat; 1:200
  • IC; rat; 1:200
In order to evaluate the isolation and culture of adult salivary gland-derived stem/progenitor cells, Abcam c-Met antibody (Abcam, ab51067) was used in flow cytometry on rat samples at 1:200 and in immunocytochemistry on rat samples at 1:200. J Tissue Eng Regen Med (2014) ncbi
R and D Systems
mouse monoclonal (95106)
  • FC; human
R and D Systems c-Met antibody (R&D, 95106) was used in flow cytometry on human samples. Oncotarget (2014) ncbi
goat polyclonal
  • WB; human
R and D Systems c-Met antibody (R&D Systems, BAF358) was used in western blot on human samples. Mol Cell Biol (2014) ncbi
mouse monoclonal (85503)
  • WB; human
R and D Systems c-Met antibody (R&D Systems Europe Ltd, MAB3581) was used in western blot on human samples. Biomaterials (2014) ncbi
not indicated
  • IHC; human
R&D rabbit anti-pMET antibody was used to perform immunohistochemistry in order to study the function of the fixative in the immunohistochemical detection of phosphoproteins.J Histochem Cytochem (2009) ncbi
not indicated
  • IP; human
  • Neut; human
R&D Systems goat polyclonal anti-human HGF-R antibody was used in immunoprecipitation and blocking or activating expriments to study the role for hepatocyte growth factor in promoting lymphatic vessel formation and function in human dermal BVEC and LEC.EMBO J (2005) ncbi
LifeSpan Biosciences
mouse monoclonal
  • IHC-P; human
LifeSpan Biosciences c-Met antibody (LSBio, LS-B2812) was used in immunohistochemistry - paraffin section on human samples. J Thorac Oncol (2015) ncbi
EMD Millipore
mouse monoclonal (4AT44)
  • FC; mouse; 1:500
EMD Millipore c-Met antibody (Millipore, MAB3729) was used in flow cytometry on mouse samples at 1:500. Springerplus (2014) ncbi
not indicated
  • WB; human
Upstate anti-Met DO-24 and DQ-13 antibodies were used in western blot and immunoprecipitation to identify LRIG1 as a novel negative regulator of the Met receptor and its role on opposing Met and Her2 synergyMol Cell Biol (2007) ncbi
not indicated
  • WB; human
Upstate anti-Met was used in western blot to detect Met in primary neonatal human melanocytes.J Biol Chem (2006) ncbi
Cell Signaling Technology
rabbit monoclonal (D1C2)
  • WB; human; fig 3g
In order to report that MET is required for neutrophil chemoattraction and cytotoxicity in response to its ligand hepatocyte growth factor, Cell Signaling Technology c-Met antibody (Cell Signaling, D1C2) was used in western blot on human samples (fig 3g). Nature (2015) ncbi
rabbit monoclonal (D26)
  • IHC-P; human
  • WB; human
In order to identify and characterize a novel variant of MET that is expressed in high-grade gliomas, Cell Signaling Technology c-Met antibody (CST, D26) was used in immunohistochemistry - paraffin section on human samples and in western blot on human samples. Acta Neuropathol (2015) ncbi
rabbit monoclonal (D1C2)
  • IHC; human; 1:300; fig 2
In order to determine the effects of targeting the VEGF and c-met pathways in clear cell renal cell carcinoma models, Cell Signaling Technology c-Met antibody (Cell Signaling, 8198) was used in immunohistochemistry on human samples at 1:300 (fig 2). Mol Cancer Ther (2015) ncbi
rabbit monoclonal (3D7)
  • IHC-P; human
  • IC; human
  • WB; human
Cell Signaling Technology c-Met antibody (cell signaling, 3129) was used in immunohistochemistry - paraffin section on human samples, in immunocytochemistry on human samples, and in western blot on human samples. PLoS ONE (2014) ncbi
rabbit monoclonal (D1C2)
  • IC; human; 1:50
Cell Signaling Technology c-Met antibody (Cell Signaling, D1C2) was used in immunocytochemistry on human samples at 1:50. Mol Endocrinol (2014) ncbi
rabbit monoclonal (3D7)
  • WB; human
Cell Signaling Technology c-Met antibody (cell signaling, 3129) was used in western blot on human samples. Biochem Biophys Res Commun (2014) ncbi
rabbit polyclonal
  • WB; human
In order to study mechanisms underlying resistance to MET monoclonal antibodies and chemical tyrosine kinase inhibitors, Cell Signaling Technology c-Met antibody (cell Signaling, 3126) was used in western blot on human samples. Mol Oncol (2014) ncbi
rabbit monoclonal (D26)
  • WB; mouse; fig s3
In order to investigate the role of mTOR and Wnt signaling proteins to c-Met TKI resistance in melanoma cell lines, Cell Signaling Technology c-Met antibody (Cell Signaling Technology, 3077) was used in western blot on mouse samples (fig s3). Cancer Biol Ther (2014) ncbi
mouse monoclonal (25H2)
  • WB; rat
Cell Signaling Technology c-Met antibody (Cell Signaling Technology, 3127) was used in western blot on rat samples. Int J Mol Med (2014) ncbi
mouse monoclonal (L41G3)
  • WB; human
Cell Signaling Technology c-Met antibody (Cell Signaling, 3148) was used in western blot on human samples. PLoS ONE (2014) ncbi
rabbit monoclonal (D26)
  • IHC-P; mouse
Cell Signaling Technology c-Met antibody (Cell Signaling, 3077) was used in immunohistochemistry - paraffin section on mouse samples. PLoS ONE (2014) ncbi
rabbit monoclonal (3D7)
  • WB; human
Cell Signaling Technology c-Met antibody (Cell Signaling, 3129) was used in western blot on human samples. PLoS ONE (2014) ncbi
rabbit monoclonal (D26)
  • WB; human
Cell Signaling Technology c-Met antibody (Cell Signaling Technology, 3077) was used in western blot on human samples. Mol Cell Biol (2014) ncbi
rabbit polyclonal
  • WB; human
Cell Signaling Technology c-Met antibody (Cell Signaling Technology, 4560) was used in western blot on human samples. Oncotarget (2014) ncbi
rabbit monoclonal (130H2)
  • IHC; human; fig 1
In order to study the ability of Met inhibitors to reverse chemoresistance in small cell lung cancer and the role of epithelial-to-mesenchymal transition, Cell Signaling Technology c-Met antibody (Cell Signaling, 130H2) was used in immunohistochemistry on human samples (fig 1). Clin Cancer Res (2014) ncbi
not indicated
  • IHC; human
Cell Signaling anti-p-Met Tyr1234 antibody was used in immunohistochemistry in order to investigate the mechanism of how Akt mediates sterol regulatory element-binding protein 1 (SREBP-1) cleavage induced by EGFR.Sci Signal (2009) ncbi
not indicated
  • WB; human
Cell Signaling Technologies anti-phospho-Met was used in western blot to detect the phosphorylation of Met in primary neonatal human melanocytes.J Biol Chem (2006) ncbi
not indicated
  • WB; human
Cell Signaling Technology monoclonal anti-Met antibody was used in western blot to study the effects of 9-cis-RA on glomerular mesangial cell activation induced by transforming growth factor (TGF) beta1.Am J Pathol (2005) ncbi
Abgent
not indicated
  • IHC; human
Abgent anti-p-Met Tyr1349 antibody was used in immunohistochemistry in order to investigate the mechanism of how Akt mediates sterol regulatory element-binding protein 1 (SREBP-1) cleavage induced by EGFR.Sci Signal (2009) ncbi
Articles Reviewed
  1. Serena Varesano et al. (2015). "Amplification of MET in a Patient with Malignant Pleural Mesothelioma".PMID 26398828
  2. Beatriz Morancho et al. (2015). "Role of ADAM17 in the non-cell autonomous effects of oncogene-induced senescence".PMID 26260680
  3. Ferenc Sipos et al. (2015). "Association of hepatocyte-derived growth factor receptor/caudal type homeobox 2 co-expression with mucosal regeneration in active ulcerative colitis".PMID 26229399
  4. Qinlong Li et al. (2015). "Metastasis initiating cells in primary prostate cancer tissues from transurethral resection of the prostate (TURP) predicts castration-resistant progression and survival of prostate cancer patients".PMID 25990623
  5. Veronica Finisguerra et al. (2015). "MET is required for the recruitment of anti-tumoural neutrophils".PMID 25985180
  6. Jessica T Chang et al. (2016). "Zebrafish cerebrospinal fluid mediates cell survival through a retinoid signaling pathway".PMID 25980532
  7. Anna C Navis et al. (2015). "Identification of a novel MET mutation in high-grade glioma resulting in an auto-active intracellular protein".PMID 25862637
  8. Yujin Kim et al. (2015). "RARβ2 hypermethylation is associated with poor recurrence-free survival in never-smokers with adenocarcinoma of the lung".PMID 25806093
  9. Giovanna Berruti et al. (2015). "USP8/UBPy-regulated sorting and the development of sperm acrosome: the recruitment of MET".PMID 25744385
  10. Mehrnoosh Saghizadeh et al. (2014). "Normalization of wound healing and stem cell marker patterns in organ-cultured human diabetic corneas by gene therapy of limbal cells".PMID 25446319
  11. Lawrence A Scheving et al. (2015). "Loss of hepatocyte EGFR has no effect alone but exacerbates carbon tetrachloride-induced liver injury and impairs regeneration in hepatocyte Met-deficient mice".PMID 25414100
  12. Eric Ciamporcero et al. (2015). "Combination strategy targeting VEGF and HGF/c-met in human renal cell carcinoma models".PMID 25381264
  13. Agnes Lim et al. (2014). "Spatially restricted Hedgehog signalling regulates HGF-induced branching of the adult prostate".PMID 25362352
  14. Irène Baccelli et al. (2014). "Co-expression of MET and CD47 is a novel prognosticator for survival of luminal breast cancer patients".PMID 25230070
  15. Peyda Korhan et al. (2014). "Reciprocal activating crosstalk between c-Met and caveolin 1 promotes invasive phenotype in hepatocellular carcinoma".PMID 25148256
  16. Antonios N Gargalionis et al. (2015). "Polycystin-1 and polycystin-2 are involved in the acquisition of aggressive phenotypes in colorectal cancer".PMID 25123959
  17. Yingqiu Xie et al. (2014). "Crosstalk between nuclear MET and SOX9/β-catenin correlates with castration-resistant prostate cancer".PMID 25099011
  18. Peyda Korhan et al. (2014). "MiR-181a-5p is downregulated in hepatocellular carcinoma and suppresses motility, invasion and branching-morphogenesis by directly targeting c-Met".PMID 25058462
  19. Valentina Martin et al. (2014). "Increase of MET gene copy number confers resistance to a monovalent MET antibody and establishes drug dependence".PMID 25011627
  20. Deven Etnyre et al. (2014). "Targeting c-Met in melanoma: mechanism of resistance and efficacy of novel combinatorial inhibitor therapy".PMID 24914950
  21. Xin Yi et al. (2014). "Hepatocyte growth factor regulates the TGF-β1-induced proliferation, differentiation and secretory function of cardiac fibroblasts".PMID 24840640
  22. Victoria A Elliott et al. (2014). "Activation of c-Met and upregulation of CD44 expression are associated with the metastatic phenotype in the colorectal cancer liver metastasis model".PMID 24823486
  23. Olga S Petrakova et al. (2014). "Comparative analysis reveals similarities between cultured submandibular salivary gland cells and liver progenitor cells".PMID 24790827
  24. Bo Cen et al. (2014). "The Pim-1 protein kinase is an important regulator of MET receptor tyrosine kinase levels and signaling".PMID 24777602
  25. Kristina H Knubel et al. (2014). "MerTK inhibition is a novel therapeutic approach for glioblastoma multiforme".PMID 24658326
  26. Anton G T Terwisscha van Scheltinga et al. (2014). "In vivo visualization of MET tumor expression and anticalin biodistribution with the MET-specific anticalin 89Zr-PRS-110 PET tracer".PMID 24614223
  27. Mitsuhiko Ota et al. (2014). "Genetic suppression of inflammation blocks the tumor-promoting effects of TGF-β in gastric tissue".PMID 24590056
  28. Jennifer D Bernet et al. (2014). "p38 MAPK signaling underlies a cell-autonomous loss of stem cell self-renewal in skeletal muscle of aged mice".PMID 24531379
  29. Noam Harpaz et al. (2014). "Expression of MACC1 and MET in inflammatory bowel disease-associated colonic neoplasia".PMID 24518605
  30. Israel Cañadas et al. (2014). "Targeting epithelial-to-mesenchymal transition with Met inhibitors reverts chemoresistance in small cell lung cancer".PMID 24284055
  31. Jason T Fong et al. (2013). "Alternative signaling pathways as potential therapeutic targets for overcoming EGFR and c-Met inhibitor resistance in non-small cell lung cancer".PMID 24223799
  32. Raimond Heukers et al. (2014). "Targeting hepatocyte growth factor receptor (Met) positive tumor cells using internalizing nanobody-decorated albumin nanoparticles".PMID 24139763
  33. Wenjuan Wu et al. (2013). "Inhibition of tumor growth and metastasis in non-small cell lung cancer by LY2801653, an inhibitor of several oncokinases, including MET".PMID 23989980
  34. Tobias Schmidt Slørdahl et al. (2013). "Anti-c-MET Nanobody - a new potential drug in multiple myeloma treatment".PMID 23952536
  35. Chung Hsin Tsai et al. (2013). "Timosaponin AIII Suppresses Hepatocyte Growth Factor-Induced Invasive Activity through Sustained ERK Activation in Breast Cancer MDA-MB-231 Cells".PMID 23878598
  36. Dong Zhou et al. (2013). "Activation of hepatocyte growth factor receptor, c-met, in renal tubules is required for renoprotection after acute kidney injury".PMID 23715119
  37. Frauke Bentzien et al. (2013). "In vitro and in vivo activity of cabozantinib (XL184), an inhibitor of RET, MET, and VEGFR2, in a model of medullary thyroid cancer".PMID 23705946
  38. Guus M Bol et al. (2013). "Expression of the RNA helicase DDX3 and the hypoxia response in breast cancer".PMID 23696831
  39. Se Jeong Lee et al. (2013). "Gene silencing of c-Met leads to brain metastasis inhibitory effects".PMID 23625089
  40. Wenrong Xu et al. (2012). "Cyclosporine A stimulated hair growth from mouse vibrissae follicles in an organ culture model".PMID 23554774
  41. L Jin et al. (2014). "The Rak/Frk tyrosine kinase associates with and internalizes the epidermal growth factor receptor".PMID 23318459
  42. Alex Hattoum et al. (2013). "Expression of hepatocyte epidermal growth factor receptor, FAS and glypican 3 in EpCAM-positive regenerative clusters of hepatocytes, cholangiocytes, and progenitor cells in human liver failure".PMID 23114924
  43. G T Gibney et al. (2013). "c-Met is a prognostic marker and potential therapeutic target in clear cell renal cell carcinoma".PMID 23022995
  44. Hyunjung Baek et al. (2014). "Autonomous isolation, long-term culture and differentiation potential of adult salivary gland-derived stem/progenitor cells".PMID 22915381
  45. Ravid Straussman et al. (2012). "Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion".PMID 22763439
  46. Alexander Swoboda et al. (2012). "MET expression in melanoma correlates with a lymphangiogenic phenotype".PMID 22570180
  47. Peizhen Hu et al. (2011). "Multiplexed quantum dot labeling of activated c-Met signaling in castration-resistant human prostate cancer".PMID 22205960
  48. Maria Tretiakova et al. (2011). "MET and phosphorylated MET as potential biomarkers in lung cancer".PMID 22181983
  49. Takashi Kato et al. (2011). "Preservations of nephrin and synaptopodin by recombinant hepatocyte growth factor in podocytes for the attenuations of foot process injury and albuminuria in nephritic mice".PMID 21342325
  50. Deliang Guo et al. (2009). "EGFR signaling through an Akt-SREBP-1-dependent, rapamycin-resistant pathway sensitizes glioblastomas to antilipogenic therapy".PMID 20009104
  51. Haggar Harduf et al. (2009). "Progesterone receptor A and c-Met mediates spheroids-endometrium attachment".PMID 19220894
  52. Rajani Kanteti et al. (2009). "PAX5 is expressed in small-cell lung cancer and positively regulates c-Met transcription".PMID 19139719
  53. Bradley Pawlikowski et al. (2009). "Analysis of human muscle stem cells reveals a differentiation-resistant progenitor cell population expressing Pax7 capable of self-renewal".PMID 19097049
  54. Janine A Burns et al. (2009). "Choice of fixative is crucial to successful immunohistochemical detection of phosphoproteins in paraffin-embedded tumor tissues".PMID 19001637
  55. David L Shattuck et al. (2007). "LRIG1 is a novel negative regulator of the Met receptor and opposes Met and Her2 synergy".PMID 17178829
  56. Mehmet Uzumcu et al. (2006). "Immunolocalization of the hepatocyte growth factor (HGF) system in the rat ovary and the anti-apoptotic effect of HGF in rat ovarian granulosa cells in vitro".PMID 16885537
  57. Gael G McGill et al. (2006). "c-Met expression is regulated by Mitf in the melanocyte lineage".PMID 16455654
  58. Xiaoyan Wen et al. (2005). "Hepatocyte growth factor receptor signaling mediates the anti-fibrotic action of 9-cis-retinoic acid in glomerular mesangial cells".PMID 16192631
  59. Kentaro Kajiya et al. (2005). "Hepatocyte growth factor promotes lymphatic vessel formation and function".PMID 16052207